[1] |
FERLAY J, COLOMBET M, SOERJOMATARAM I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-53.
doi: 10.1002/ijc.31937
pmid: 30350310
|
[2] |
DAS R, GREGORY P A, FERNANDES R C, et al. MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2[J]. Cancer Res, 2017, 77(4): 1021 -1034.
doi: 10.1158/0008-5472.CAN-16-2529
pmid: 28011622
|
[3] |
FIZAZI K, SMITH M R, TOMBAL B. Clinical development of darolutamide: a novel androgen receptor antagonist for the treatment of prostate cancer[J]. Clin Genitourin Cancer, 2018, 16(5): 332-40.
doi: 10.1016/j.clgc.2018.07.017
|
[4] |
MOILANEN A-M, RIIKONEN R, OKSALA R, et al. Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies[J]. Sci Rep, 2015, 5: 12007.
doi: 10.1038/srep12007
|
[5] |
CHEN B C. New drug for the treatment of prostate cancer-darolutamide[J]. Herb Med, 2020, 39(3): 422-427.
doi: 10.3870/j.issn.1004-0781.2020.03.033
|
|
陈本川. 治疗前列腺癌新药—达洛鲁胺(darolutamide)[J]. 医药导报, 2020, 39(3): 422-427.
doi: 10.3870/j.issn.1004-0781.2020.03.033
|
[6] |
FAN Z Z, SU L L, HU W, et al. Graphical synthetic routes to darolutamide[J]. Chin J Med Chem, 2022, 32(8): 652-656.
|
|
范昭泽, 苏立林, 胡伟, 等. 达罗他胺合成路线图解[J]. 中国药物化学杂志, 2022, 32(8): 652-656.
|
[7] |
GERD W, OLLI T, HARRI S, et al. Androgen receptor modulating compounds: WO2011051540A1[P]. 2010-10-27.
|
[8] |
OLLI T, GERD W, HARRI S, et al. Androgen receptor modulating carboxamides: WO2012143599A1[P]. 2012-10-26.
|
[9] |
YU J, ZHOU P, HU M, et al. Discovery and biological evaluation of darolutamide derivatives as inhibitors and down-regulators of wild-type AR and the mutants[J]. Eur J Med Chem, 2019, 182: 111608.
doi: 10.1016/j.ejmech.2019.111608
|
[10] |
HORST F. Basic one-and two-dimensional NMR spectroscopy (5th Ed.)[M]. New York, 2010.
|
[11] |
ZHAI C G, WANG P C, SHAN Y B, et al. Structure characterization and analgesic activity of novel pyrazolo[3,4-d]pyrimidin-4-one Derivatives[J]. Chinese J Magn Reson, 2023, 40(1): 1-9.
|
|
翟重钢, 汪鹏程, 单玉宝, 等. 新型吡唑并[3,4-d]嘧啶-4-酮类衍生物的结构表征和镇痛活性[J]. 波谱学杂志, 2023, 40(1): 1-9.
|
[12] |
WANG Z H, HU X, WANG T, et al. NMR spectroscopic studies on C-2 monosubstituted norbornene derivatives[J]. Chinese J Magn Reson, 2021, 38(3): 323-335.
|
|
王子豪, 徐赫, 汪涛, 等. 外型和内型C-2位单取代降冰片烯衍生物的核磁共振波谱研究[J]. 波谱学杂志, 2021, 38(3): 323-335.
|